Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
The Journal of Allergy and Clinical Immunology|October 24, 2007
Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification CommitteeRaif S Geha, Luigi D Notarangelo, Jean-Laurent Casanova, et al.The Journal of Allergy and Clinical Immunology|December 17, 2009
Primary immunodeficiencies: 2009 update, Luigi D Notarangelo, Alain Fischer, et al.Lancet (London, England)|February 25, 2003
Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99Corinne Antoine, Susanna Müller, Andrew Cant, et al.Pediatrics|March 4, 2009
Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiencyWaseem Qasim, Marina Cavazzana-Calvo, E Graham Davies, et al.Frontiers in Immunology|May 9, 2012
Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiencyWaleed Al-Herz, Aziz Bousfiha, Jean-Laurent Casanova, et al.Plos One|April 22, 2009
Chronic granulomatous disease: the European experienceJ Merlijn van den Berg, Elsbeth van Koppen, Anders Ahlin, et al.Current Gene Therapy|May 19, 2015
Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of TimingUlrich Siler, Anna Paruzynski, Heidi Holtgreve-Grez, et al.The Journal of Allergy and Clinical Immunology|September 7, 2010
Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitisLena F Schimke, Julie Sawalle-Belohradsky, Joachim Roesler, et al.Journal of Clinical Immunology|May 10, 2013
A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedsideAhmed Aziz Bousfiha, Leïla Jeddane, Fatima Ailal, et al.Nature Medicine|April 4, 2006
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1Marion G Ott, Manfred Schmidt, Kerstin Schwarzwaelder, et al.Pageof 4